SARS-CoV-2 Nsp2 reprograms host immunity to drive pathogenic inflammation
Émile Lacasse, Isabelle Dubuc, Joannie Leclerc…·Louis Flamand
This study shows that SARS-CoV-2 Nsp2 drives immunopathology by reprogramming host immune responses, leading to more severe inflammation compared to its deletion mutant.